A carregar...
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
BACKGROUND: Although anti-VEGF therapy of exudative AMD with bevacizumab and ranibizumab proved efficacious in the majority of patients, CNV activity does not respond to continued treatment after repeated injections in a considerable amount of patients. These are referred to as nonresponders. A chan...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017123/ https://ncbi.nlm.nih.gov/pubmed/24722504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.64 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|